Biofourmis
Latest round
- Series D
Last raised
- Apr 2022
Total raised
- $368M
Investors
- 14
About Biofourmis
Biofourmis Inc.Founded in 2015 in Boston, US, Biofourmis Inc. focuses on revolutionizing healthcare through innovative technology. The company has undergone strategic pivots to enhance its service offerings.Biofourmis offers a technology platform that transforms healthcare delivery and drug lifecycle management. This includes solutions for remote patient monitoring and home healthcare management, such as Hospital at Home programs, aimed at improving patient outcomes and facilitating seamless care transitions.S.In 2018, Biofourmis reported revenue of USD 250,388, with an EBITDA of USD -3,096,233, generated through subscription-based models and strategic partnerships with healthcare organizations. This merger is poised to enhance their technological capabilities and market reach.
Who invested in Biofourmis
14 investors across 5 rounds
See all investors in Biofourmis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Biofourmis
Who invested in Biofourmis?
Biofourmis has 14 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biofourmis raised?
Biofourmis has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Biofourmis last raise money?
Biofourmis's most recent round on record is a Series D, in Apr 2022.
What does Biofourmis do?
Biofourmis is a healthcare it company.
Where is Biofourmis headquartered?
Biofourmis is headquartered in Boston, US.
Which VCs invest in companies like Biofourmis?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Biofourmis's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series D
Raising like Biofourmis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.